linsidomine has been researched along with thromboxanes in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bordet, JC; Croset, M; Lagarde, M | 1 |
| Bordet, JC; Lagarde, M | 1 |
| Levy-Toledano, S; Maclouf, J; Rendu, F; Weill, D | 1 |
| Block, HU; Förster, W; Heinroth, I | 1 |
| Schrör, K; Strobach, H; Weber, AA | 1 |
| Bode-Böger, SM; Böger, RH; Frölich, JC; Galland, A | 1 |
1 trial(s) available for linsidomine and thromboxanes
| Article | Year |
|---|---|
Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro.
Topics: Adult; Antithrombins; Arginine; Blood Platelets; Cyclic GMP; Enzyme Inhibitors; Humans; In Vitro Techniques; Infusions, Intravenous; Male; Molsidomine; Nitric Oxide Synthase; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxane A2; Thromboxane B2; Thromboxanes | 1998 |
5 other study(ies) available for linsidomine and thromboxanes
| Article | Year |
|---|---|
Differential effect of SIN-1 on thromboxane and prostacyclin formation in platelets and endothelial cells.
Topics: Arachidonic Acids; Blood Platelets; Cells, Cultured; Endothelium, Vascular; Epoprostenol; Humans; Molsidomine; Oxygen Consumption; Thromboxanes; Umbilical Veins; Vasodilator Agents | 1989 |
Modulation of prostacyclin/thromboxane formation by molsidomine during platelet-endothelial cell interactions.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Cell Communication; Cells, Cultured; Endothelium, Vascular; Epoprostenol; Humans; Molsidomine; Thromboxanes | 1988 |
[Effects of SIN-1 on the early phases of blood platelet activation].
Topics: Blood Platelets; Humans; Molsidomine; Platelet Aggregation; Serotonin; Thromboxanes | 1987 |
SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
Topics: Animals; Arachidonic Acids; Blood Platelets; Drug Interactions; Female; Humans; Indoles; Male; Molsidomine; Oxadiazoles; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Pyridines; Rabbits; Sydnones; Thromboxane A2; Thromboxanes | 1982 |
Direct inhibition of platelet function by organic nitrates via nitric oxide formation.
Topics: Adenosine Triphosphate; Animals; Anisotropy; Blood Platelets; Cells, Cultured; Cyclic GMP; Dose-Response Relationship, Drug; Esters; Fibroblasts; Humans; Lung; Molsidomine; Nitrates; Nitric Oxide; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Thromboxanes | 1993 |